Mind bomb 2 limits inflammatory dermatitis in Sharpin mutant mice independently of cell death

• Published in: PNAS nexus Vol. 3; no. 1; p. pgad438
• Main Authors: Simpson, Daniel S, Anderton, Holly, Yousef, Jumana, Vaibhav, Vineet, Cobbold, Simon A, Bandala-Sanchez, Esther, Kueh, Andrew J, Dagley, Laura F, Herold, Marco J, Silke, John, Vince, James E, Feltham, Rebecca
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.01.2024
• Subjects: Analysis; Biological, Health, and Medical Sciences; Cell death; Dermatitis; Genetic aspects; Identification and classification; Inflammation; Properties; Skin; Ubiquitin; Australia; cpdm; dermatitis; mind bomb 2; TNF; Sharpin
• ISSN: 2752-6542; 2752-6542
• DOI: 10.1093/pnasnexus/pgad438

Skin inflammation is a complex process implicated in various dermatological disorders. The chronic proliferative dermatitis (cpd) phenotype driven by the cpd mutation (cpdm) in the Sharpin gene is characterized by dermal inflammation and epidermal abnormalities. Tumour necrosis factor (TNF) and caspase-8-driven cell death causes the pathogenesis of mice; however, the role of mind bomb 2 (MIB2), a pro-survival E3 ubiquitin ligase involved in TNF signaling, in skin inflammation remains unknown. Here, we demonstrate that MIB2 antagonizes inflammatory dermatitis in the context of the cpd mutation. Surprisingly, the role of MIB2 in limiting skin inflammation is independent of its known pro-survival function and E3 ligase activity. Instead, MIB2 enhances the production of wound-healing molecules, granulocyte colony-stimulating factor, and Eotaxin, within the skin. This discovery advances our comprehension of inflammatory cytokines and chemokines associated with cpdm pathogenesis and highlights the significance of MIB2 in inflammatory skin disease that is independent of its ability to regulate TNF-induced cell death.